Systemic inflammatory response following acute traumatic brain injury

Area of Science:

• Neuroscience
• Immunology
• Critical Care Medicine

Background:

• Acute traumatic brain injury (TBI) initiates a cascade of inflammatory mediators.
• These mediators can trigger systemic inflammatory response syndrome (SIRS), leading to a self-perpetuating cycle of hyperinflammation.
• SIRS can result in complement deficits and coagulopathy, complicating TBI management.

Purpose of the Study:

• To elucidate the complex interplay between inflammatory responses following acute TBI.
• To understand the role of compensatory anti-inflammatory response syndrome (CARS) in TBI.
• To highlight the potential detrimental effects of CARS activation in TBI patients.

Main Methods:

• Review of inflammatory pathways involved in TBI.
• Analysis of the mechanisms underlying SIRS and CARS.
• Examination of the consequences of CARS activation, including immunosuppression.

Main Results:

• Acute TBI triggers SIRS, characterized by escalating inflammation and tissue damage.
• CARS attempts to counteract SIRS by targeting key inflammatory mediators like IL-1 beta, IL-6, and TNF-alpha.
• However, CARS activation in TBI can paradoxically lead to immunosuppression.

Conclusions:

• Uncontrolled SIRS following TBI can lead to a detrimental cycle of hyperinflammation.
• While CARS aims to mitigate SIRS, its activation in TBI can result in immunosuppression.
• This immunosuppression increases the risk of multi-organ dysfunction syndrome (MODS) and mortality in TBI patients.